Pfizer, Inc. Share Price

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 01:30:25 11/05/2024 am IST 5-day change 1st Jan Change
28.01 USD -0.60% Intraday chart for Pfizer, Inc. +0.72% -2.71%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 60.41B 5,043B Sales 2025 * 62.71B 5,235B Capitalization 159B 13,252B
Net income 2024 * 7.78B 649B Net income 2025 * 11.29B 942B EV / Sales 2024 * 3.59 x
Net Debt 2024 * 58.11B 4,852B Net Debt 2025 * 49.97B 4,172B EV / Sales 2025 * 3.33 x
P/E ratio 2024 *
19.5 x
P/E ratio 2025 *
13.7 x
Employees 88,000
Yield 2024 *
5.96%
Yield 2025 *
6.07%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.60%
1 week+0.72%
Current month+9.33%
1 month+6.34%
3 months+1.63%
6 months-4.99%
Current year-2.71%
More quotes
1 week
27.32
Extreme 27.32
28.49
1 month
25.20
Extreme 25.2
28.49
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 01/93/01
Director of Finance/CFO 59 02/22/02
Chief Tech/Sci/R&D Officer - 01/19/01
Members of the board TitleAgeSince
Director/Board Member 66 01/20/01
Director/Board Member 64 23/17/23
Director/Board Member 60 27/13/27
More insiders
Date Price Change Volume
10/24/10 28.01 -0.60% 25,849,775
09/24/09 28.18 -0.32% 47,831,087
08/24/08 28.27 +1.80% 39,087,790
07/24/07 27.77 -1.38% 65,606,379
06/24/06 28.16 +1.26% 59,899,707

Delayed Quote Nyse, May 11, 2024 at 01:30 am IST

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01 USD
Average target price
31.94 USD
Spread / Average Target
+14.02%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW